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Abstract
Background: Intravenous fluids are commonly prescribed in childhood. 0.9 % saline is the most-used fluid in
pediatrics as resuscitation or maintenance solution. Experimental studies and observations in adults suggest that
0.9 % saline is a poor candidate for fluid resuscitation. Although anesthesiologists, intensive care specialists,
perioperative physicians and nephrologists have been the most active in this debate, this issue deserves some
physiopathological considerations also among pediatricians.
Results: As compared with so-called “balanced” salt crystalloids such as lactated Ringer, administration of large
volumes of 0.9 % saline has been associated with following deleterious effects: tendency to hyperchloremic
metabolic acidosis (called dilution acidosis); acute kidney injury with reduced urine output and salt retention;
damaged vascular permeability and stiffness, increase in proinflammatory mediators; detrimental effect on coagulation
with tendency to blood loss; detrimental gastrointestinal perfusion and function; possible uneasiness at the bedside
resulting in unnecessary administration of more fluids. Nevertheless, there is no firm evidence that these adverse effects
are clinically relevant.
Conclusions: Intravenous fluid therapy is a medicine like insulin, chemotherapy or antibiotics. Prescribing fluids
should fit the child’s history and condition, consider the right dose at the right rate as well as the electrolyte levels
and other laboratory variables. It is unlikely that a single type of fluid will be suitable for all pediatric patients.
“Balanced” salt crystalloids, although more expensive, should be preferred for volume resuscitation, maintenance
and perioperatively. Lactated Ringer appears unsuitable for patients at risk for brain edema and for those with
overt or latent chloride-deficiency. Finally, in pediatrics there is a need for new fluids to be developed on the basis
of a better understanding of the physiology and to be tested in well-designed trials.
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Omnia venenum sunt: nec sine
veneno quicquam existit.
Dosis sola facit,
ut venenum non fit.1
Paracelsus (1493-1541)
Background
Intravenous fluids are commonly prescribed in childhood.
The ideal fluid achieves the desired effect with no tissue
storage, no adverse electrolyte, acid-base, hematological or
immunomodulating effects, is compatible with other med-
icines, affordable and available with long shelf life and rea-
sonable storage requirements. However, no fluid currently
meets all of these criteria [1, 2].
Fifteen years ago, it was speculated that parenteral
maintenance therapy with a Na+-concentration lower than
in blood, as proposed by Malcolm Holliday (1924–2014)
in 1957, sometimes results in hyponatremic encephalo-
pathy. The advice was followed by a controversy. In the
meantime, trials comparing low-Na+ fluids with 0.9 % sa-
line confirmed that traditional maintenance therapy puts
patients at risk of hyponatremia [2, 3]. As a consequence,
maintenance low-Na+ fluids are currently the exception,
not the rule. Perioperative therapy with a Na+-content
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close to the physiologic range of 135-145 mmol/L has also
been recommended [4].2
Recent studies suggest that 0.9 % saline is a poor can-
didate for fluid resuscitation. Although anesthesiologists,
intensive care specialists, perioperative physicians and
nephrologists have been the most active in this debate,
this issue deserves some thoughts among pediatricians.
0.9 % saline – Ringer’s and Hartmann’s solutions
Saline (0.9 % NaCl solution), or physiological or normal sa-
line (as it is frequently called), is the most-used fluid in
pediatrics as resuscitation or maintenance solution and as
vehicle for the administration of drugs. This is not without
reason: it has been shown that saline use is equivalent and,
in some circumstances, even superior to colloid solutions
such as 4 % albumin or hydroxyethyl starch solutions [5].
Saline came into being following the ingenious in vitro
studies, published in 1883, performed by the Dutch
physiological chemist Hartog Hamburger (1859–1924).
He noted that red blood cells were less likely to lyse in a
NaCl solution of 0.9 % than in more diluted solutions
[6, 7]. However, the composition of 0.9 % saline largely
differs from that of blood (Fig. 1).
More physiologic solutions with a salt composition
more close to that of blood than 0.9 % saline, subsequently
referred to as so-called “balanced” salt crystalloids, were
soon developed. Approximately 110 years ago, Sydney
Ringer (1834–1910), an Australian physician, introduced a
NaCl solution containing some K+ and Ca++ to promote
contraction of isolated heart [6, 7]. Eighty years ago, Alexis
Hartmann (1898–1964), an American pediatrician, added
the non–Cl- anion lactate to prevent metabolic acidosis
[6, 7]. The solution developed by A. Hartmann, currently
termed either Hartmann’s solution or lactated Ringer’s so-
lution, eventually replaced the original Ringer’s solution.
The composition of this solution has been slightly modi-
fied over the years (there is also some variation in its com-
position as supplied by different manufacturers).
0.9 % saline versus so-called “balanced” salt crystalloids
Large volumes of Cl--rich fluids such as 0.9 % saline re-
sults in some adverse effects [6–8], as depicted in Table 1.
Effects on acid-base balance
Cl--rich fluids containing neither HCO3
- nor another
anion that can be metabolized to HCO3
-, cause an incre-
ment in Cl-- and a decrease in HCO3
--concentration,
a condition called hyperchloremic metabolic acidosis.
Saline-induced acidosis, traditionally called dilution acid-
osis, is a short-lived phenomenon unless sustained by a
kidney injury. Overall, however, the prognosis of inten-
sive care unit patients with hyperchloremic acidosis is by
far better than that of patients with non-hyperchloremic,
mostly lactic metabolic acidosis [6, 7].
Effects on renal function
The high Cl--content of saline may cause an acute kidney
injury with Na+-retention. Following factors likely underlie
this injury: 1. Increased Cl--content in blood is followed
by a decreased proximal tubular Cl--reabsorption and thus
Fig. 1 Semi-quantitative Gamble’s diagram representing the Na+-, K+-,
Cl--, base- and albuminate-concentration in blood, 0.9 %
saline solution, lactated Ringer’s solution and so-called more “balanced”
salt crystalloids. The Na+-concentration is higher in 0.9 % saline
(≈155 mmol/L) and lower in lactated Ringer (≈130 mmol/L) than in
blood (≈140 mmol/L). On the contrary, the concentration of this
cation is almost identical in the “balanced” salt crystalloids and in
blood (≈140 mmol/L). The Cl--concentration is higher in 0.9 % saline
(≈155 mmol/L), in lactated Ringer (≈110 mmol/L) and in the “balanced”
salt crystalloid (≈125 mmol/L) containing acetate ≈ 25-30 mmol/L than
in blood (≈100 mmol/L). The concentration of this anion is similar in
the “balanced” salt crystalloid containing acetate ≈ 50 mmol/L and in
blood (≈100 mmol/L). For simplicity purposes, calcium, magnesium
and inorganic phosphate are omitted
Table 1 Potentially deleterious effects of high Cl--content
secondary to administration of large volume of 0.9 % saline
addressed in the literature
• Hyperchloremic metabolic acidosis (traditionally called dilution
acidosis)
• Acute kidney injury with reduced urine output and increase in
interstitial fluid volume
• Hyperkalemia (K+ mobilized from the intracellular space)
• Damaged endothelial surface layer with increased vascular
permeability and stiffness
• Increase in proinflammatory mediators and tendency to infections
• Detrimental effect on coagulation with tendency to blood loss
• Detrimental gastrointestinal perfusion and function
• Possible uneasiness at the bedside resulting in unnecessary
administration of more fluids
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by an increased renal tubular Cl-; 2. Increased renal tubu-
lar Cl- results in its entry into the macula densa leading to
adenosine release, which causes afferent arteriolar vaso-
constriction; 3. Increased afferent arteriolar resistance re-
duces renal flow and glomerular filtration rate leading to
reduced urine output and Na+-excretion. Nevertheless,
although human studies confirm that large volumes of
saline cause detriment to renal function, there is no firm
evidence that this adverse effect is clinically relevant (this
might simply reflect lack of data) [6, 7, 9].
Effects on potassium level
As many “balanced” salt crystalloids (e.g.: lactated Ringer)
contain K+, they are customarily contraindicated in the
presence of hyperkalemia. However, the literature compar-
ing saline with “balanced” salt crystalloids does not con-
firm this view. Three factors might account for this
observation: a) the K+-content in “balanced” crystalloids
of ≤5 mmol/L gets rapidly diluted in extracellular fluid
after infusion; b) contrary to saline that causes hyper-
chloremic acidosis, “balanced” salt crystalloids do not
mobilize K+ from the intracellular space (Fig. 2); c) kidney
injury is less common in subjects infused with “balanced”
salt crystalloids [6, 7].
Effects on vascular permeability and stiffness
Large volumes of saline cause a greater increase in inter-
stitial fluid volume (and, hence, edema) than “balanced”
salt crystalloids. This might reflect the aforementioned
acute kidney injury with Na+-retention that results after
saline infusion as well as an increased vascular perme-
ability secondary to hyperchloremic metabolic acidosis.
The luminal side of vascular endothelial cells is covered
by a layer of mucopolysaccharide macromolecules, called
endothelial surface layer or endothelial glycocalix (Fig. 3),
which is the key determinant of vascular permeability.
The integrity of this layer and thereby the potential for the
development of interstitial edema is often altered under
inflammatory conditions when salt crystalloids are com-
monly used, such as sepsis and after surgery or trauma
(Fig. 3). Preliminary data suggest that this layer might be
better preserved following resuscitation with lactated
Ringer’s than with other fluids (unfortunately, no data are
available with saline). Natriuretic peptides are a further
factor that might damage the endothelial surface layer and
perhaps also increase vascular stiffness [6, 7].
Inflammation
In experimental animals, the administration of saline is
followed by an increase in proinflammatory mediators.
Furthermore, in patients undergoing surgery, an increased
risk of postoperative infections was observed in patients
receiving saline compared with a “balanced” salt crystal-
loid [6, 7].
Effects on coagulation and intestine
Limited evidence suggests that large volumes of saline
have a detrimental effect on coagulation as well as on
gastrointestinal perfusion and function [6, 7].
Possible uneasiness at the bedside
Under conditions of shock, sepsis and fluid losses from
the gastrointestinal tract, the acidosis that occurs with
saline is frequently interpreted as a sign of hypovolemia
inviting the prescription of more fluids. Consequently,
the persistence of acidosis during saline administration
could result in the unnecessary administration of even
more fluids [7].
More “balanced” salt crystalloids
As described above, the ionic composition of “balanced”
crystalloids closely mimics the ionic make-up of the
aqueous fraction of blood (Fig. 1). Unfortunately, in lac-
tated Ringer’s solution, a commonly prescribed “balanced”
solution, the Na+-level of ≈ 130 mmol/L is lower than in
extracellular fluid (≈140 mmol/L). Consequently, this
Fig. 2 Effect of hyperchloremic metabolic acidosis on circulating K+
level. In hyperchloremic metabolic acidosis some extracellular H+
shifts into the intracellular space. Since Cl- remains largely in the
extracellular fluid, a shift of K+ from the intracellular to the
extracellular fluid occurs. No tendency towards hyperkalemia occurs in
normochloremic metabolic acidosis, such as lactate acidosis or
ketoacidosis, because organic anions enter the intracellular fluid
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solution decreases the circulating Na+-level and has a po-
tential to increase brain water content and subsequently
to cause hyponatremic encephalopathy. A disproportion-
ally large brain, a high brain-to-skull ratio, and a reduced
Na+-pump activity notoriously put infants especially at
risk of hyponatremic encephalopathy [10]. “Balanced”
crystalloids with a Na+-level of ≈ 140 mmol/L and acetate
instead of lactate were soon developed. Regrettably, little
attention has been paid to the Cl--concentration, which is
higher in 0.9 % saline (≈155 mmol/L), lactated Ringer
(≈110 mmol/L) and in the “balanced” salt crystalloid
with ≈ 25-30 mmol/L of acetate (≈125 mmol/L) than in
blood (≈100 mmol/L). The concentration of Cl- is close to
that in blood in the “balanced” salt crystalloid with ≈
50 mmol/L of acetate.
The Na+/Cl--ratio of 1.0 in 0.9 % saline is far lower than
that of ≈ 1.4 in normal blood, denoting a tendency to cause
hyperchloremic acidosis [1, 11, 12]. The Na+/Cl--ratio is
still lower than in blood in lactate Ringer (≈1.2) and in the
crystalloid containing ≈ 25-30 mmol/L of acetate (≈1.1) but
normal (≈1.4) in the crystalloid containing ≈ 50 mmol/L of
acetate [1, 11, 12].
Lactate undergoes gluconeogenesis leading to increased
levels of glucose suggesting a restrictive use in diabetes
mellitus. Furthermore, administration of lactated solutions
might confound the interpretation of lactate as a bio-
marker of tissue oxygenation, as raised lactate levels occur
as a result of excessive infusion of a lactated solution. A
“balanced” salt crystalloid containing acetate instead of
lactate is in use since more than 50 years for severe child-
hood diarrhea. Acetate has some advantages over lactate: it
stabilizes pH more rapidly than lactate and is metabolized
in various tissues, whereas lactate is metabolized predom-
inantly in the liver. On the other hand, acetate might pos-
sess some cardiodepressant and vasodilator effects [6, 7].
Bicarbonate, the logical alternative to lactate or acetate,
is impracticable due to the difficulty in storage and its sen-
sitivity to CO2. Predictably, a solution with a physiological
HCO3
--concentration was withdrawn because of bicarbon-
ate precipitations [6, 7].
“Restricted” versus “liberal” fluid administration strategy
Finally, some recent data indicate that a restricted fluid
administration strategy might be superior to a more
liberal one for fluid resuscitation, for maintenance and
perioperatively [3, 9–13].
Conclusions
Intravenous fluid therapy is complex. It is a medicine
like insulin, chemotherapy or antibiotics. Prescribing
fluids should fit the child’s history and condition, con-
sider the right dose at the right rate as well as the elec-
trolyte levels and other laboratory variables. Anticipating
and recognizing possible side effects and frequently
assessing the patient’s condition is crucial [2].
Used generally to describe various solutions with a com-
position close to blood, it appears that none of the so-
called “balanced” salt crystalloids is really physiological.
Unsurprisingly, therefore, an ideal salt crystalloid has not
been identified yet [1]. Moreover, it is unlikely that a single
type of fluid, a kind of “one-size-fits-all” approach, will be
suitable for all pediatric patients [2]. There is no doubt
that large volumes of 0.9 % saline may impair renal func-
tion and vascular permeability. It has been therefore stated
that 0.9 % saline is a “problem”, not a “solution” [14].
Hence, “balanced” salt crystalloids, although more ex-
pensive, should be preferred for volume resuscitation,
maintenance and perioperatively [4, 5]. Lactated Ringer
appears unsuitable for patients at risk for brain edema
(e.g.: neurosurgery, head trauma, central nervous system
infection) and for those with overt or latent Cl--deficiency
(e.g.: vomiting, salt losing renal tubular disorders, electro-
lyte disturbances caused by diuretics). In these two condi-
tions, saline still remains the solution of choice [5, 10].
Obviously, in patients with fluid volume depletion associ-
ated electrolyte and acid-base abnormalities, the goal of
initial management is volume resuscitation, not the repair
of the associated metabolic abnormalities. Furthermore,
ad hoc prepared solutions are needed in some rather rare
circumstances. Yet, the process of prescribing, ordering
and preparing these fluids offers several opportunities for
error.
Fig. 3 The luminal side of vascular endothelium is covered by a
layer of mucopolysaccharide macromolecules of up to 1 μm
thickness called endothelial surface layer or endothelial glycocalyx.
This layer is the key determinant of vascular permeability. The integrity
of the layer and thereby the potential for the development of interstitial
edema, which varies substantially among organ systems, is often
altered under inflammatory conditions when 0.9 % saline is prescribed,
such as sepsis and after surgery or trauma. 1. adhesion molecules;
2. glycosaminoglycans; 3. glycocalix-bound mediators; 4. endothelial
cells; 5. endothelial basement membrane
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Finally, in pediatrics there is a need for novel fluids to
be developed on the basis of a better understanding of
the physiology and to be tested in well-designed trials.
Only then will the “great fluid debate” be solved.
Endnotes
1All things are poison, and nothing is without poison;
only the dose permits something not to be poisonous.
2Considering the potential of hypoglycemia in infancy,
0.9% saline in 5% glucose in water (which contains ap-
proximately glucose 50 g/L and NaCl 9 g/L) is currently
considered the safest composition for maintenance fluid
therapy. Since perioperative administration of 5% glucose
for prevention of hypoglycemia may result in stress-
induced hyperglycemia, fluid therapy with a Na+-content
close to the physiologic range with addition of 1.0-2.5% in-
stead of 5.0% glucose is currently advised in this setting.
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